Psilera has closed an oversubscribed $8.8M raised #SeriesSeed funding round! #FirstInClass and #FirstInHuman data expected in 2027. Read the full details in the press release below: prnewswire.com/news-releases… #MindfulMedicine #Psychedelics #Neuroplastogens

Most IND timelines slip long before regulators see the package. The root cause? Early decisions made in silos. Join our live webinar on Wednesday, March 18th, 2026 🕒 8am PDT | 11am EDT | 3pm GMT | 4pm CET Our panel of experts will break down how startups can: • Integrate non‑clinical, CMC & regulatory strategy early • Avoid rework, misalignment & delays • Build a realistic, de‑risked path to FIH • Communicate effectively with investors 👉 Save your seat using the link in the comments below: discover.pharmaignite.com/st… #IND #FirstInHuman #RegulatoryStrategy #CMC #BiotechStartups

Thrilled to share our first-in-human study 🧬 on ⁶⁸Ga-CBP8 PET/MR in Crohn’s disease → showing the ability to distinguish inflammatory vs fibrotic-inflammmatory strictures → pathology-validated 🔗 rdcu.be/e4iKz #FirstInHuman #NucMed #PETMR #IBD #MGH #Harvard

Grateful to an amazing team: Taieb, Turyan, Abu Salman, Jubeh, Fink & Wolak 🔗 jacc.org/doi/10.1016/j.jacca… #TAVR #StructuralHeart #FirstInHuman #ATLAS #CardiologyInno

@DrEmmaSearle #EarlyPhase #Haematology Lead @ #TheChristie #Manchester @TheChristieNHS #MM #AML #MDS #FirstInHuman #Phase1

Our experts, from Venn Life Sciences and CRS, Early Phase, will be hosting a workshop in Leiden. Join us on 21st October at the Plus Ultra Building in Leiden to attend our in-person workshop “From Preclinical to Clinical: Essential Steps Toward First-In-Human Studies” to help you understand the considerations you need to think about when planning your clinical development, from pre-clinical to first-in-human. Our consultants from our non-clinical, clinical, CMC and clinical pharmacology teams will be on hand to answer your questions and work through the practicalities. Please register your interest in taking part via the link below. We are planning to host workshops in other cities in the UK and Europe so please do follow our page to keep up-to-date, if you are not able to join on this occasion but would like to in future. 📅 Date: Tuesday 21 October 2025 🕒 Time: 2-5pm CET 📍Venue: Plus Ultra Leiden 🧑‍💼Trainers: Senior CMC, non-clinical and clinical experts Register here: vennlifesciences.com/event/f… #HVO #Venn #CMC #Consultancy #Workshop #Netherlands #FirstinHuman #ScientificResearch

First-in-Human cases  with ViewFlex™ SE EnSite™ X v5 at #ArrhythmiaResearchGroup Group and St. Bernards Healthcare as part of ViewFlex SE Trial. Pushing the boundaries of EP workflows with the first clinical use of the @AbbottCardio ViewFlex™ SE ICE catheter, now paired with AI-assisted map creation, Grid Mapping, and real-time Contact Assessment using Farapulse and PulseSelect PFA systems. Some of the features that caught my eye:     Physician-ready geometry with EnSite Echo     Simplified ICE navigation to stay focused on therapy     Single-handed deflection via auto-locking mechanism     Color-coded deflection indicators for intuitive control     Softer, more stable catheter with enhanced torque response      Sterile tip-to-connector (no sterile bagging)      Single catheter cable = less clutter, more efficiency     Contact is critical in PFA — and the new Contact Index on EnSite X v5 lets you validate contact instantly and tag lesions appropriately. Powered by AI. Backed by precision. Designed for EPs. A simplified, smarter, and safer workflow is best workflow ever. #FirstInHuman #ViewFlexSE #AIinHealthcare #ICEIntegration #CatheterInnovation #PFA #MedTechInnovation #epeeps @AbbottNews

US surgeons perform world’s first in-human bladder transplant yespunjab.com/?p=125270 #BladderTransplant #MedicalBreakthrough #OrganTransplant #USCSurgery #UCLAHealth #UrologyInnovation #LifeSavingSurgery #FirstInHuman #TransplantSuccess

First in Human (FiH) Trials: The Critical First Step in Drug Development The path from research to treatment begins with First-in-Human trials. FiH studies generate essential safety, dosing, and pharmacokinetic data—shaping the path toward regulatory approval and market introduction. As a part of the hVIVO Group, CRS Clinical Research Services specializes in FiH trials, ensuring a seamless and reliable transition from lab to life. With our expertise in early-phase clinical research, we help turn research into real-world impact. Visit the CRS website to explore how we can support your next breakthrough: crs-earlyphase.com #CRS #EarlyPhase #FirstinHuman #hVIVO

Another amazing accomplishment of early phase studies in Malaysia! We are ecstatic to share that Dr. Voon Pei Jye (medical oncologist) and his outstanding study team at Sarawak General Hospital was named Global First Recruiter after successfully enrolled 1st first trial participant ahead other global trial sites in an Advanced Solid Tumor First-in-Human (FIH) study! Our special thanks to our hardworking SCs, Fong Yian Ching, Cindy, Haziqah, Lin Hui and Li Fang—for their incredible efforts in making this achievement possible. This was coincidentally the very first FIH by BeiGene (a global, science-driven oncology company), and spells great beginnings to the collaboration fostered. BeiGene - CRM inked formalised its partnership back in Dec 2024, to enhance Malaysia's clinical research ecosystem, focusing on capability development and expanding clinical trial operations. We are already observing a tremendous impact through the growing number of studies invested by this organisation in Malaysia, and the accomplishment of this early phase study further emphasises Malaysia's capabilities in delivering FIH studies. This is just the beginning of the impactful outcomes we can achieve together. Here’s to advancing clinical research in Malaysia! #clinicalresearchmy #advancingclinicalresearch⁠ #askusaboutclinicalresearch⁠ #recruitmentachievement #firstinhuman

Congratulations to Dr. Iafrati and his team in Nashville for performing one of the first in-stent restenosis cases using PowerWire Pro this past April. Read more about the first commercial use here: bit.ly/3KtLP2L #Firstinhuman #IRad #MedEd #PowerWirePro #MedTwitter

@MarcelaMaus Discussing how to incorporate more safety thru #productdesign #protocoldesign #characterization #releasecriteria to innovate #firstinhuman #clinicaltrial. #cancer #celltherapy #cgt @parkerici @CancerResrch @FDACBER @FDAOncology

Curious to learn more about our First-in-Human Study of BRB-002? Check out our press release here: brbio.com/bitterroot-bio-ann… #BitterrootBio #BRB002 #FirstinHuman #heartdisease #cardiovascular #drugdevelopment

$CLNN CEO Rob Etherington shared the founding ideas and development process behind Clene Nanomedicine’s #CNMAu8 on the @VialTrials #FirstinHuman podcast. Listen as Rob describes #CNMAu8’s progress in #ALS and #MS clinical trials: bit.ly/3TRHRoX

The first participants in @OsivaxVaccines first-in-human trial of #sarbecovirus vaccine has been dosed with #ovx003 to kick off the trial. #vaccinenation #vaccine #vaccines #coronavirus #sarscov2 #firstinhuman #osivax vaccinenation.org/technology…

#portfolionews I Great news for @KynexisTx . Kicking off 2024 with a major #milestone achieved! #vc #Schizophrenia #CNS #ClinicalTrials #CIAS #FirstInHuman

News from @OxfordVacGroup @UniofOxford @PSIOxford as #nipah vaccine trial begins in humans with @CEPIvaccines funding. #vaccinenation #vaccine #vaccines #nipahvirus #chadox1 #oxford #firstinhuman vaccinenation.org/technology…

Even after >700 #firstinhuman phase I trials, our @SarahCannonDocs team still pauses to mark that first dose ever of a novel therapeutic, that first patient🙏, first caregiver🙏, first oncologist (👏@SAStricklandMD), first research team (👏@mkvallone et al) — a time point that reflects the peak of collaboration, courage, and hope!

- sains dan kewujudan terapi baharu menerusi kaedah penyelidikan klinikal pada masa depan. #clinicalresearchmy #advancingclinicalresearch⁠ #askusaboutclinicalresearch⁠ #firstinhuman

Great opportunity to discuss research at the #ukcrfnetwork conference in Nottingham. Developing our #phase1 & #FirstInHuman capability in #Wrexham on the @northwalescrf. Exciting times @Parexel @ascensionq @NIHR_UKCRFN @BetsiCadwaladr @ResearchWales @NIHRCRF_Lpool @NIHRresearch